- Home
- CMPR vs ALVO Comparison
CMPR vs ALVO Comparison
Compare CMPR & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CMPR | ALVO |
|---|---|---|
| Founded | 1994 | 2013 |
| Country | Ireland | Luxembourg |
| Employees | N/A | N/A |
| Industry | Publishing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.6B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CMPR | ALVO |
|---|---|---|
| Price | $73.71 | $4.65 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $80.50 | $10.67 |
| AVG Volume (30 Days) | 179.5K | ★ 592.2K |
| Earning Date | 10-29-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.37 | 0.24 |
| Revenue | ★ $3,461,387,000.00 | $573,350,000.00 |
| Revenue This Year | $7.87 | $34.94 |
| Revenue Next Year | $4.82 | $39.55 |
| P/E Ratio | $53.96 | ★ $19.36 |
| Revenue Growth | 3.65 | ★ 45.55 |
| 52 Week Low | $35.21 | $4.32 |
| 52 Week High | $85.56 | $13.70 |
Technical Indicators
Market Signals| Indicator | CMPR | ALVO |
|---|---|---|
| Relative Strength Index (RSI) | 64.63 | 30.43 |
| Support Level | $67.27 | $5.05 |
| Resistance Level | $70.57 | $5.49 |
| Average True Range (ATR) | 3.13 | 0.29 |
| MACD | 0.51 | 0.04 |
| Stochastic Oscillator | 91.05 | 24.66 |
Price Performance
Historical ComparisonAbout CMPR Cimpress plc (Ireland)
Cimpress PLC invests in and builds customer-focused, entrepreneurial, mass-customization businesses for the long term. Mass customization seeks to produce goods and services to meet individual customer needs with near mass production efficiency. Its products and services include a broad range of marketing materials, business cards, signage, promotional products, logo apparel, packaging, books and magazines, wall decor, photo merchandise, invitations and announcements, design and digital marketing services, and other categories. The company's segment includes Vista; PrintBrothers; The Print Group; National Pen and All Other Businesses. It generates maximum revenue from the Vista segment.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.